GNMK Crosses Above Average Analyst Target

In recent trading, shares of GenMark Diagnostics, Inc. (GNMK) have crossed above the average analyst 12-month target price of $19.60, changing hands for $22.45/share..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.